🔎 Trials Near Me

Utama › Purpura Trombositopenik Idiopatik › Connecticut

Kajian klinikal Purpura Trombositopenik Idiopatik di Connecticut

3 kajian untuk Purpura Trombositopenik Idiopatik sedang mencari peserta di lokasi di Connecticut.

Bandar di Connecticut

Teks kajian rasmi (Bahasa Inggeris)

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

  • Yale Cancer Center, New Haven
  • Stamford Hospital, Stamford
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07421167

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  • Yale New Haven Hospital, New Haven
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07104565

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

  • Yale University School of Medicine, New Haven
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT06544499

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.